Perseus Acquisition/Recapitalization Fund, L.L.C.
Director10% Owner

Perseus Acquisition/Recapitalization Fund, L.L.C. insider trades: Cardiac Science (CSCX) stock sales

Director, Cardiac Science Last trade Apr 15, 2010 5 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
5
Open-market trades
since 2010
1
Company
last trade 2010

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Perseus Acquisition/Recapitalization Fund, L.L.C. reports to the SEC

Open-market buys and sales

5 trades reported on SEC Form 4, newest first

DateStockTypeValue
Apr 15, 2010CSCX↓ Sell$215K
Apr 12, 2010CSCX↓ Sell$57K
Apr 7, 2010CSCX↓ Sell$73K
Apr 1, 2010CSCX↓ Sell$71K
Mar 29, 2010CSCX↓ Sell$160K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Perseus Acquisition/Recapitalization Fund, L.L.C.'s insider trades

Perseus Acquisition/Recapitalization Fund, L.L.C. is a director at Cardiac Science (CSCX). Since Mar 29, 2010, it has reported no open-market purchases and 5 sales worth $575K on SEC Form 4. There have been no open-market trades in the last 12 months.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CSCX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.